Respuesta :

Answer:

Protecting Human Subjects in Clinical Trials. This issue has generated considerable debate since 1999, when 18-year-old Jesse Gelsinger died while participating in a gene therapy trial at the University of Pennsylvania. ...

Affordability. ...

Privacy. ...

Stem Cell Research. ...

Defending the United States Against Bioterrorism.

Explanation:

Answer:

Protecting Human Subjects in Clinical Trials. This issue has generated considerable debate since 1999, when 18-year-old Jesse Gelsinger died while participating in a gene therapy trial at the University of Pennsylvania. ...

Affordability. ...

Privacy. ...

Stem Cell Research. ...

Defending the United States Against Bioterrorism.

Explanation:

I did the thing